Clinical trials A+AVD superior to ABVD for the first-line treatment of newly diagnosed stage III or IV Hodgkin... Read more
Clinical trials FDA approves pemigatinib for myeloid/lymphoid neoplasms patients with altered FGFR Read more
Clinical trials Adding elotuzumab to lenalidomide and dexamethasone does not improve PFS in patients with newl... Read more
Clinical trials LISO-CEL SHOWS SUPERIOR EFFICACY VS. STANDARD OF CARE AS SECOND-LINE TREATMENT FOR PRIMARY REF... Read more
Clinical trials Adding ibrutinib to bendamustine and rituximab prolongs progression-free survival in older pat... Read more
Clinical trials Three-agent regimen provides ‘unprecedented’ PFS benefit in patients with relapsed multipl... Read more
Clinical trials Circulating tumour cells and disease staging in newly diagnosed multiple myeloma patients Read more
Clinical trials PTCy plus TK is safe and effective in reducing GVHD in older patients with blood cancers Read more
